85 related articles for article (PubMed ID: 19879773)
1. Serum evaluation of soluble interferon-alpha/beta receptor and high-sensitivity C-reactive protein for diagnosis of the patients with gastrointestinal and hepatobiliary-pancreatic cancer.
Miyake K; Imura S; Nishioka M; Batmunkh E; Sugimoto K; Ohmoto Y; Shimada M
Cytokine; 2010 Mar; 49(3):251-5. PubMed ID: 19879773
[TBL] [Abstract][Full Text] [Related]
2. Serum testosterone:dihydrotestosterone ratio and CA 19-9 in the diagnosis of pancreatic cancer.
Robles-Díaz G; Díaz-Sánchez V; Fernández-del Castillo C; Morales M; Aceves G; Galván E; Altamirano A
Am J Gastroenterol; 1991 May; 86(5):591-4. PubMed ID: 2028950
[TBL] [Abstract][Full Text] [Related]
3. [Which cut-off value of high sensitivity C- reactive protein is more valuable for determining long- term prognosis in patients with acute coronary syndrome?].
Kiliç T; Ural E; Oner G; Sahin T; Kiliç M; Yavuz S; Kanko M; Kahraman G; Bildirici U; Berki KT; Ural D
Anadolu Kardiyol Derg; 2009 Aug; 9(4):280-9. PubMed ID: 19666429
[TBL] [Abstract][Full Text] [Related]
4. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve.
Kim HJ; Kim MH; Myung SJ; Lim BC; Park ET; Yoo KS; Seo DW; Lee SK; Min YI
Am J Gastroenterol; 1999 Jul; 94(7):1941-6. PubMed ID: 10406263
[TBL] [Abstract][Full Text] [Related]
5. [The clinical applications of serum tumor markers in gastroenterology].
González Martínez M; Marín López E
Rev Gastroenterol Mex; 1993; 58(2):103-7. PubMed ID: 7747020
[TBL] [Abstract][Full Text] [Related]
6. Serum high sensitivity C-reactive protein and cognitive function in elderly women.
Komulainen P; Lakka TA; Kivipelto M; Hassinen M; Penttilä IM; Helkala EL; Gylling H; Nissinen A; Rauramaa R
Age Ageing; 2007 Jul; 36(4):443-8. PubMed ID: 17537742
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of latent changes in blood coagulation by the determination of plasma thrombin-antithrombin complex in gastrointestinal neoplasms].
Guidi L; Bartoloni C; Pellicanò P; Cappelli A; Cursi F; Pili R; Tricerri A; Patriarca F; Gambassi G
Clin Ter; 1991 Mar; 136(6):367-73. PubMed ID: 1828201
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic usefulness of Ca 19-9 antigen in cancer of the pancreas and neoplasms of the pancreato-biliary intersection].
Robles-Diáz G; Aceves G; Galván E
Gac Med Mex; 1990; 126(2):78-82; discussion 82-3. PubMed ID: 2387490
[TBL] [Abstract][Full Text] [Related]
9. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of transforming growth factor alpha in gastrointestinal cancer patients.
Moskal TL; Huang S; Ellis LM; Fritsche HA; Chakrabarty S
Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):127-31. PubMed ID: 7742720
[TBL] [Abstract][Full Text] [Related]
11. Serum cathepsin B and plasma urokinase-type plasminogen activator levels in gastrointestinal tract cancers.
Herszényi L; István G; Cardin R; De Paoli M; Plebani M; Tulassay Z; Farinati F
Eur J Cancer Prev; 2008 Oct; 17(5):438-45. PubMed ID: 18714186
[TBL] [Abstract][Full Text] [Related]
12. CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions.
Marrelli D; Caruso S; Pedrazzani C; Neri A; Fernandes E; Marini M; Pinto E; Roviello F
Am J Surg; 2009 Sep; 198(3):333-9. PubMed ID: 19375064
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus.
Mojahedi MJ; Bonakdaran S; Hami M; Sheikhian MR; Shakeri MT; Aiatollahi H
Iran J Kidney Dis; 2009 Jan; 3(1):12-6. PubMed ID: 19377253
[TBL] [Abstract][Full Text] [Related]
14. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma.
Hashimoto K; Ikeda Y; Korenaga D; Tanoue K; Hamatake M; Kawasaki K; Yamaoka T; Iwatani Y; Akazawa K; Takenaka K
Cancer; 2005 May; 103(9):1856-64. PubMed ID: 15779015
[TBL] [Abstract][Full Text] [Related]
15. High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis.
Dessein PH; Joffe BI; Stanwix AE
J Rheumatol; 2004 Jun; 31(6):1095-7. PubMed ID: 15170920
[TBL] [Abstract][Full Text] [Related]
16. Clinical application of a new monoclonal antibody (19B7) against PIVKA-II in the diagnosis of hepatocellular carcinoma and pancreatobiliary malignancies.
Nakao A; Taniguchi K; Inoue S; Takeda S; Harada A; Nonami T; Watanabe K; Takagi H
Am J Gastroenterol; 1997 Jun; 92(6):1031-4. PubMed ID: 9177525
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
[TBL] [Abstract][Full Text] [Related]
18. CEACAM1, a novel serum biomarker for pancreatic cancer.
Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
[TBL] [Abstract][Full Text] [Related]
19. Serum C-reactive protein in the differential diagnosis of ovarian masses.
Hefler-Frischmuth K; Hefler LA; Heinze G; Paseka V; Grimm C; Tempfer CB
Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):65-8. PubMed ID: 19619929
[TBL] [Abstract][Full Text] [Related]
20. [Value of C-reactive protein in the diagnosis of arteriosclerosis in patients with essential hypertension].
Deng LH; Huang R; Wu ZL; Xu DL
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):521-4. PubMed ID: 19304543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]